Silver North Resources Financials

TARSF

Source SEC Filings (10-K/10-Q) Updated Mar 4, 2026 Currency USD FYE March

This page shows Silver North Resources (TARSF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

2.74x

For every $1 of reported earnings, Silver North Resources generates $2.74 in operating cash flow (-$1.1M OCF vs -$406K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Revenue

N/A

EBITDA

N/A

Free Cash Flow

N/A

Net Income

-$406K

YoY+80.2%

Silver North Resources reported -$406K in net income in fiscal year 2025. This represents an increase of 80.2% from the prior year.

EPS (Diluted)

N/A

Cash & Debt

$710K

YoY+11.4%

Silver North Resources held $710K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

48M

Silver North Resources had 48M shares outstanding in fiscal year 2025. This represents a decrease of 70.0% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

TARSF Income Statement

Metric	FY25	FY22	FY21	FY20	FY19
Revenue	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A
Net Income	-$406K+80.2%	-$2.1M-118.5%	-$939K+11.1%	-$1.1M-5.9%	-$997K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q3'21	Q3'20
Revenue	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A
Net Income	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A

TARSF Balance Sheet

Metric	FY25	FY22	FY21	FY20	FY19
Total Assets	N/A	N/A	N/A	N/A	N/A
Current Assets	$2.4M+153.4%	$933K+53.5%	$607K+26.6%	$480K	N/A
Cash & Equivalents	$710K+11.4%	$637K+54.4%	$413K+14.0%	$362K+2.7%	$353K
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$76K+184.3%	$27K-39.2%	$44K+219.4%	$14K	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	N/A	N/A	N/A	N/A
Current Liabilities	$1.4M+29.5%	$1.1M+139.0%	$462K-15.4%	$546K	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A
Total Equity	$9.4M+33.9%	$7.0M-11.7%	$7.9M+84.1%	$4.3M+13.2%	$3.8M
Retained Earnings	-$24.8M-15.0%	-$21.6M-10.5%	-$19.6M-5.0%	-$18.6M	N/A

Metric	Q3'22	Q3'21	Q3'20
Total Assets	N/A	N/A	N/A
Current Assets	$933K+53.5%	$607K+26.6%	$480K
Cash & Equivalents	$637K+54.4%	$413K+14.0%	$362K
Inventory	N/A	N/A	N/A
Accounts Receivable	$27K-39.2%	$44K+219.4%	$14K
Goodwill	N/A	N/A	N/A
Total Liabilities	N/A	N/A	N/A
Current Liabilities	$1.1M+139.0%	$462K-15.4%	$546K
Long-Term Debt	N/A	N/A	N/A
Total Equity	$7.0M-11.7%	$7.9M+84.1%	$4.3M
Retained Earnings	-$21.6M-10.5%	-$19.6M-5.0%	-$18.6M

TARSF Cash Flow Statement

Metric	FY25	FY22	FY21	FY20	FY19
Operating Cash Flow	-$1.1M-154.7%	-$436K+67.4%	-$1.3M-103.9%	-$657K+14.8%	-$771K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$1.5M-2907.6%	-$49K+98.5%	-$3.3M-429.6%	-$628K+10.8%	-$704K
Financing Cash Flow	$3.8M+415.1%	$730K-84.5%	$4.7M+238.4%	$1.4M-23.9%	$1.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q3'21	Q3'20
Operating Cash Flow	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A

TARSF Financial Ratios

Metric	FY25	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A
Current Ratio	1.65+0.8	0.84-0.5	1.31+0.4	0.88	N/A
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A

Metric	Q3'22	Q3'21	Q3'20
Gross Margin	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A
Current Ratio	0.84-0.5	1.31+0.4	0.88
Debt-to-Equity	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A

Frequently Asked Questions

Is Silver North Resources profitable?

No, Silver North Resources (TARSF) reported a net income of -$406K in fiscal year 2025.

What is Silver North Resources's operating cash flow?

Silver North Resources (TARSF) generated -$1.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

How many shares does Silver North Resources have outstanding?

Silver North Resources (TARSF) had 48M shares outstanding as of fiscal year 2025.

What is Silver North Resources's current ratio?

Silver North Resources (TARSF) had a current ratio of 1.65 as of fiscal year 2025, which is generally considered healthy.

What is Silver North Resources's cash runway?

Based on fiscal year 2025 data, Silver North Resources (TARSF) had $710K in cash against an annual operating cash burn of $1.1M. This gives an estimated cash runway of approximately 8 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Are Silver North Resources's earnings high quality?

Silver North Resources (TARSF) has an earnings quality ratio of 2.74x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.